K-numberK251883
Device nameMIM – LesionID Pro
ApplicantMim Software, Inc.
Product codeLLZ
Device classClass II
Decision dateDec 11, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

MIM – LesionID Pro is a software application that assists trained medical professionals in evaluating PSMA PET/CT and SPECT/CT studies by automating hotspot segmentation and physiological uptake removal to streamline Total Tumor Burden (TTB) statistics generation. The software requires users to review, edit, and confirm segmentations before final analysis and operates on multiple platforms including Windows, macOS, and Linux-based systems supporting various DICOM medical imaging modalities.

Technological characteristics

Key differences from the predicate include automated physiological uptake identification and removal (versus manual in predicate), automated reference region generation in liver and mediastinum bloodpool ROIs (versus manual only in predicate), and automated TTB ROI generation and quantification (versus manual only in predicate). The subject device integrates with MIM Workflows and MIM Assistant for workflow automation using modular functions, and includes Contour ProtégéAI+ for automatic contouring of normal structures.

Test standards cited

Not stated in this summary.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →